HCV viral load levels during treatment and speed of decline do not predict cure with interferon-free therapy
Daily PrEP leads to better adherence and protective drug levels in women
High-dose rifampicin may shorten time to TB clearance
End-stage liver disease is a concern for people with HIV and hepatitis B or C co-infection
HCV sexual transmission linked to anal sex, drug use, lower CD4 count
Experimental agents reverse HIV latency and help immune system fight HIV-infected cells
Early antiretroviral treatment reduces, but does not eliminate HIV reservoir
Cabotegravir and rilpivirine effective for HIV maintenance therapy at 96 weeks
FRAX fracture prediction tool underestimates fracture risk in people with HIV
Sustained virological response represents a long-term cure for people with hepatitis C treated with sofosbuvir
Inflammation and gut leakage remains elevated in people with HIV despite early antiretroviral treatment
Screening may miss pre-cancerous anal lesions in women with HIV
Re-infection due to ongoing risk probably the cause of HCV recurrence after SVR
Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people
Studies offer mounting evidence that statins may reduce the risk of heart disease in people living with HIV
